Jefferies Group LLC Iveric Bio, Inc. Put Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	BUY	$9.12 - $18.9 $80,256 - $166,320	8,800 Added 110.0%	16,800 $161,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $153,216 - $317,520	16,800 New	16,800 $162,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $110,640 - $150,240	-8,000 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$7.07 - $17.5 $56,560 - $140,000	8,000 New	8,000 $129,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $56,560 - $140,000	8,000 New	8,000 $130,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.